8VP1 Stock Overview
Engages in the health data and point-of-care technologies business in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Avricore Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.035 |
| 52 Week High | CA$0.20 |
| 52 Week Low | CA$0.015 |
| Beta | -1.9 |
| 11 Month Change | -67.73% |
| 3 Month Change | -81.22% |
| 1 Year Change | -63.78% |
| 33 Year Change | -70.42% |
| 5 Year Change | 294.44% |
| Change since IPO | -97.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8VP1 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -59.9% | -0.6% | -1.3% |
| 1Y | -63.8% | -33.0% | 7.4% |
Return vs Industry: 8VP1 underperformed the German Healthcare Services industry which returned -33.1% over the past year.
Return vs Market: 8VP1 underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| 8VP1 volatility | |
|---|---|
| 8VP1 Average Weekly Movement | 20.0% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8VP1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8VP1's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Hector Bremner | avricore.com |
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018.
Avricore Health Inc. Fundamentals Summary
| 8VP1 fundamental statistics | |
|---|---|
| Market cap | €4.14m |
| Earnings (TTM) | -€1.99k |
| Revenue (TTM) | €3.06m |
1.4x
P/S Ratio-2,075x
P/E RatioIs 8VP1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8VP1 income statement (TTM) | |
|---|---|
| Revenue | CA$4.48m |
| Cost of Revenue | CA$2.86m |
| Gross Profit | CA$1.62m |
| Other Expenses | CA$1.62m |
| Earnings | -CA$2.92k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.000029 |
| Gross Margin | 36.16% |
| Net Profit Margin | -0.065% |
| Debt/Equity Ratio | 0% |
How did 8VP1 perform over the long term?
See historical performance and comparison